Antonio David
Prieto Merino
Profesor/a Titular Universidad
London School of Hygiene & Tropical Medicine
Londres, Reino UnidoLondon School of Hygiene & Tropical Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (92)
2024
2023
-
Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: An implementation study
BMJ Open, Vol. 13, Núm. 1
-
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 2, pp. 365-381
2022
-
A Bayesian hierarchical model with integrated covariate selection and misclassification matrices to estimate neonatal and child causes of death
Journal of the Royal Statistical Society. Series A: Statistics in Society, Vol. 185, Núm. 4, pp. 2097-2120
-
A systematic review of statistical methodology used to evaluate progression of chronic kidney disease using electronic healthcare records
PLoS ONE, Vol. 17, Núm. 7 July
-
Association between practice coding of chronic kidney disease (CKD) in primary care and subsequent hospitalisations and death: a cohort analysis using national audit data
BMJ Open, Vol. 12, Núm. 10
-
Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals
The Lancet Child and Adolescent Health, Vol. 6, Núm. 2, pp. 106-115
-
Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention
PLoS ONE, Vol. 17, Núm. 5 May
-
High sensitivity troponin and COVID-19 outcomes
Acta Cardiologica, Vol. 77, Núm. 1, pp. 81-88
-
Novel multimorbidity clusters in people with eczema and asthma: a population-based cluster analysis
Scientific Reports, Vol. 12, Núm. 1
-
Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease
Circulation, Vol. 146, Núm. 3, pp. 240-248
2021
-
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)
JACC: Clinical Electrophysiology, Vol. 7, Núm. 2, pp. 210-222
-
Changes in gut microbiota correlates with response to treatment with probiotics in patients with atopic dermatitis. A post hoc analysis of a clinical trial
Microorganisms, Vol. 9, Núm. 4
-
Clinical outcomes in a primary-level noncommunicable disease programme for Syrian refugees and the host population in Jordan: A cohort analysis using routine data
PLoS Medicine, Vol. 18, Núm. 1
-
Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial
JMIR mHealth and uHealth, Vol. 9, Núm. 7
-
Estimating proportion of days covered (PDC) using real-world online medicine suppliers’ datasets
Journal of Pharmaceutical Policy and Practice, Vol. 14, Núm. 1
-
Feasibility of evaluation of the natural history of kidney disease in the general population using electronic healthcare records
Clinical Kidney Journal, Vol. 14, Núm. 6, pp. 1603-1609
2020
-
Bayesian hierarchical methods in the detection of potentially teratogenic first-trimester medications
Pharmacoepidemiology and Drug Safety, Vol. 29, Núm. 3, pp. 337-346
-
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic
British Journal of Dermatology
-
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
British Journal of Dermatology, Vol. 182, Núm. 6, pp. 1423-1429